Abiomed to Ring NASDAQ Closing Bell, Celebrating Regulatory Progress and Global Leadership in Circulatory Care for ... (RedNova)
Abiomed, Inc. (NASDAQ: ABMD) today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will ring the closing bell of the NASDAQ Stock Market on December 28, 2006 at 4 pm ET.

Anika Therapeutics Receives FDA Approval For Its Cosmetic Tissue Augmentation Product (Medical News Today)
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has received FDA approval for its cosmetic tissue augmentation ("CTA") product. CTA is an injectable soft tissue filler for facial wrinkles, scar remediation and lip augmentation. The product is based on Anika's chemically modified hyaluronic acid (HA) proprietary technology and incorporates lidocaine, a local anesthetic. [click link ...